Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
[Effect of hypertension on outcomes of patients with COVID-19]
H U Chengyi1,2, Xiao Lushan2, Zhu Hongbo2,3
1Department of Medical Quality Management, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Insights
Hypertension significantly increases the risk of bacterial infections in COVID-19 patients. These patients exhibit higher neutrophil counts and require more antibiotic treatments, underscoring the need for caution against secondary infections.
Area of Science:
- Infectious Diseases
- Cardiovascular Medicine
- Critical Care
Background:
- Hypertension is a prevalent comorbidity associated with severe outcomes in various infections.
- The impact of hypertension on COVID-19 patient outcomes, particularly concerning secondary infections, requires further elucidation.
Purpose of the Study:
- To investigate the influence of hypertension on the clinical characteristics and outcomes of patients diagnosed with COVID-19.
- To assess the association between hypertension and the incidence of bacterial infections in COVID-19 patients.
Main Methods:
- A matched cohort study involving 442 COVID-19 patients (61 with hypertension, 381 normotensive) admitted between January 1 and March 18, 2020.
- Patients were matched 1:1 for age and gender, excluding other comorbidities to isolate the effect of hypertension.
- Analysis included clinical characteristics, laboratory findings, and clinical outcomes in 32 matched pairs.
Main Results:
- COVID-19 patients with hypertension showed a higher likelihood of developing bacterial infections (P=0.002) compared to normotensive patients.
- Hypertensive patients exhibited elevated neutrophil counts (P=0.007), neutrophil/lymphocyte ratio (P=0.045), and lactate dehydrogenase levels (P=0.035).
- Increased prevalence of bilateral patchy opacities on chest CT (P=0.012) and higher rates of antibiotic (P=0.035) and corticosteroid (P=0.035) use were observed in the hypertension group.
Conclusions:
- Hypertension is a significant risk factor for bacterial infections in COVID-19 patients.
- Hypertensive COVID-19 patients demonstrate inflammatory markers indicative of higher infection risk and necessitate increased antibiotic treatment.
- Clinical vigilance and preventive measures against bacterial infections are crucial for hypertensive individuals with COVID-19.
Objective:
To determine the impact of hypertension on the outcomes of patients with COVID-19.
Methods:
This matched cohort study was conducted among a total 442 patients with COVID-19 admitted in Honghu People's Hospital and First Affiliated Hospital of Nanchang University between January 1 to March 18, 2020, including 61 patients with hypertension and 381 normotensive patients. To minimize the effects of the confounding factors including age, gender and other comorbidities, we excluded patients with comorbidities other than hypertension, and matched the patients with and without hypertension for age and gender at a 1:1 ratio. We analyzed the clinical characteristics, laboratory findings and clinical outcomes of in 32 matched pairs of patients with and without hypertension.
Results:
Compared with the normotensive patients, COVID-19 patients with hypertension were more likely to develop bacterial infections (P=0.002) and had higher neutrophil counts (P=0.007), neutrophil/lymphocyte ratio (P=0.045), and lactate dehydrogenase levels (P=0.035). A greater proportion of patients had bilateral patchy opacities on chest CT (P=0.012) in the hypertension group than in the normotensive group. COVID-19 patients with hypertension group were more likely to receive antibiotics (P=0.035) and corticosteroid therapies (P=0.035).
Conclusions:
Hypertension increases the risk of bacterial infection in patients with COVID-19. Hypertensive patients with COVID-19 have higher neutrophil counts and neutrophil/ lymphocyte ratios and are more likely to require treatment with antibiotics. Hypertensive patients with COVID-19 should therefore take cautions to avoid bacterial infections.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
08:34Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Hypertension I: Introduction
Hypertension V: Nursing Management